OTC: HKMPF - Hikma Pharmaceuticals PLC

Yield per half year: -4.48%

Share chart Hikma Pharmaceuticals PLC

Extended chart Simple chart
Financial Markets by TradingView

About

Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals. The Generics segment offers oral and other non-injectable generic products for the retail market. The Branded segment offers branded generics and in-licensed products to retail and hospital markets.

more details
The company provides its products in various therapeutic areas, including respiratory, oncology, and pain management. It also offers its products in solid, semi-solid, liquid, and injectable final dosage forms. The company operates in the United Kingdom, rest of Europe, North America, the Middle East, North Africa, and internationally. Hikma Pharmaceuticals PLC was founded in 1978 and is headquartered in London, the United Kingdom.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

EBITDA 0.659
EV/EBITDA 9.9
Industry Pharmaceuticals
P/BV 2.95
P/E 12.93
P/S 2.85
Sector Health Care
Валюта usd
Валюта отчета usd
Выручка 2.21
Див.доход ао 3.22
Дивиденд ао 0.47
Сайт https://www.hikma.com
Цена ао 23.37
Число акций ао 0.22237 млрд
Change price per day: 0% (24.12)
Change price per week: 0% (24.12)
Change price per month: -1.43% (24.47)
Change price per 3 month: -6.15% (25.7)
Change price per half year: -4.48% (25.25)
Change price per year: +5.86% (22.785)
Change price per 3 year: -30.09% (34.5)
Change price per 5 year: 0% (24.12)
Change price per 10 year: 0% (24.12)
Change price per year to date: +0.2494% (24.06)
All parameters

Underestimation

Title Value Grade
P/S 1.76 8
P/BV 2.29 6
P/E 26.6 6
EV/EBITDA 6.94 9
Total: 7.63

Efficiency

Title Value Grade
ROA, % 4.06 1
ROE, % 8.64 3
Total: 4

Dividends

Title Value Grade
Div yield, % 3.15 7.88
DSI 1 10
Total: 8.39

Debt

Title Value Grade
Debt/EBITDA 1.3 8
Total: 7.2

Growth impulse

Title Value Grade
Yield Revenue, % 30.09 5
Yield Ebitda, % -8.99 0
Yield EPS, % -57.49 0
Total: 2.2
More

Head Job title Payment Year of birth
Mr. Mazen Samih Taleb Darwazah Executive Vice Chairman & President of MENA 2.3M 1958 (67 years)
Mr. Khalid Waleed Hosny Al Nabilsi Chief Financial Officer N/A 1972 (53 years)
Mr. Guy Featherstone Associate Director of Investor Relations N/A
Mr. Bassam Wael Rushdi Kanaan CFA, CPA Executive Vice President of Corporate Development and M&A N/A 1965 (60 years)
Mr. Hussein Omar Arkhagha Chief People Officer N/A
Ms. Susan Ringdal Executive Vice President of Strategic Planning & Global Affairs N/A
Mr. Samuel Park General Counsel N/A
Engineer Said Samih Taleb Darwazah Executive Chairman 2.8M 1957 (68 years)
Mr. Riad Ali Mishlawi CEO & Director 1.1M 1964 (61 year)
Patricia Bousfield Chief Information Officer N/A

Address: United Kingdom, London WS HR, 1 New Burlington Place - open in Google maps, open in Yandex maps
Website: https://www.hikma.com